Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 133

1.

Effect of Incorporation of Antifungal Agents on the Ultimate Tensile Strength of Temporary Soft Denture Liners.

Neppelenbroek KH, Lima JFM, Hotta J, Galitesi LL, Almeida ALPF, Urban VM.

J Prosthodont. 2018 Feb;27(2):177-181. doi: 10.1111/jopr.12660. Epub 2017 Nov 14.

PMID:
29135059
2.

Congenital Cutaneous Candidiasis: Prompt Systemic Treatment Is Associated With Improved Outcomes in Neonates.

Kaufman DA, Coggins SA, Zanelli SA, Weitkamp JH.

Clin Infect Dis. 2017 May 15;64(10):1387-1395. doi: 10.1093/cid/cix119.

PMID:
28158439
3.

Topical Antimycotics for Oral Candidiasis in Warfarin Users.

Hellfritzsch M, Pottegård A, Pedersen AJ, Burghle A, Mouaanaki F, Hallas J, Grove EL, Damkier P.

Basic Clin Pharmacol Toxicol. 2017 Apr;120(4):368-372. doi: 10.1111/bcpt.12722. Epub 2017 Jan 11.

4.

Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.

Sardi JC, Gullo FP, Freires IA, Pitangui NS, Segalla MP, Fusco-Almeida AM, Rosalen PL, Regasini LO, Mendes-Giannini MJ.

Diagn Microbiol Infect Dis. 2016 Dec;86(4):387-391. doi: 10.1016/j.diagmicrobio.2016.08.002. Epub 2016 Aug 8.

PMID:
27638348
5.

Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.

Mukherjee PK, Chen H, Patton LL, Evans S, Lee A, Kumwenda J, Hakim J, Masheto G, Sawe F, Pho MT, Freedberg KA, Shiboski CH, Ghannoum MA, Salata RA; Oral HIVAIDS Research Alliance (OHARA)AIDS Clinical Trials Group (ACTG) 5265 Team.

AIDS. 2017 Jan 2;31(1):81-88.

6.

Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis.

Lyu X, Zhao C, Yan ZM, Hua H.

Drug Des Devel Ther. 2016 Mar 16;10:1161-71. doi: 10.2147/DDDT.S100795. eCollection 2016. Review.

8.

The global effect of exposing bakers' yeast to 5-fluoruracil and nystatin; a view to Toxichip.

Graziano S, Gullì M, Maestri E, Marmiroli N.

Chemosphere. 2016 Feb;145:470-9. doi: 10.1016/j.chemosphere.2015.11.045. Epub 2015 Dec 13.

PMID:
26694798
9.

Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization.

Bassi P, Kaur G.

Eur J Pharm Biopharm. 2015 Oct;96:173-84. doi: 10.1016/j.ejpb.2015.07.018. Epub 2015 Jul 30.

PMID:
26235393
10.

A novel in vitro assay for assessing efficacy and toxicity of antifungals using human leukaemic cells infected with Candida albicans.

Boros-Majewska J, Turczyk Ł, Wei X, Milewski S, Williams DW.

J Appl Microbiol. 2015 Jul;119(1):177-87. doi: 10.1111/jam.12817. Epub 2015 May 1.

11.

Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.

Fan S, Liu X, Wu C, Xu L, Li J.

Mycopathologia. 2015 Feb;179(1-2):95-101. doi: 10.1007/s11046-014-9827-4. Epub 2014 Nov 22.

PMID:
25416649
12.

Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis.

Boros-Majewska J, Salewska N, Borowski E, Milewski S, Malic S, Wei XQ, Hayes AJ, Wilson MJ, Williams DW.

Med Microbiol Immunol. 2014 Oct;203(5):341-55. doi: 10.1007/s00430-014-0343-4. Epub 2014 Jun 13.

PMID:
24924305
13.

Nystatin-induced acute generalized exanthematous pustulosis.

Ocerin-Guerra I, Gomez-Bringas C, Aspe-Unanue L, Ratón-Nieto JA.

Actas Dermosifiliogr. 2012 Dec;103(10):927-8. doi: 10.1016/j.adengl.2012.10.002. Epub 2012 Nov 11. No abstract available.

PMID:
23149047
14.

Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin.

Blyth CC, Barzi F, Hale K, Isaacs D.

J Paediatr Child Health. 2012 Sep;48(9):846-51. doi: 10.1111/j.1440-1754.2012.02543.x. Review.

PMID:
22970680
15.

Predictive genomic biomarkers for drug-induced nephrotoxicity in mice.

Kondo C, Aoki M, Yamamoto E, Tonomura Y, Ikeda M, Kaneto M, Yamate J, Torii M, Uehara T.

J Toxicol Sci. 2012;37(4):723-37.

16.

Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice.

Semis R, Nili SS, Munitz A, Zaslavsky Z, Polacheck I, Segal E.

J Antimicrob Chemother. 2012 Jul;67(7):1716-21. doi: 10.1093/jac/dks117. Epub 2012 Apr 11.

PMID:
22499997
17.

Comparison of therapeutic effect of aqueous extract of garlic and nystatin mouthwash in denture stomatitis.

Bakhshi M, Taheri JB, Shabestari SB, Tanik A, Pahlevan R.

Gerodontology. 2012 Jun;29(2):e680-4. doi: 10.1111/j.1741-2358.2011.00544.x. Epub 2011 Nov 30.

PMID:
22126338
18.

Is ototopical nystatin ototoxic? A chinchilla model.

Daniel SJ, Sahmkow S, Akinpelu OV.

Otolaryngol Head Neck Surg. 2011 Dec;145(6):1022-4. doi: 10.1177/0194599811418407. Epub 2011 Aug 22.

PMID:
21860059
19.

New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei.

Brautaset T, Sletta H, Degnes KF, Sekurova ON, Bakke I, Volokhan O, Andreassen T, Ellingsen TE, Zotchev SB.

Appl Environ Microbiol. 2011 Sep;77(18):6636-43. doi: 10.1128/AEM.05780-11. Epub 2011 Jul 15.

20.

Effects and mechanisms of action of polyene macrolide antibiotic nystatin on Babesia gibsoni in vitro.

Yamasaki M, Tamura N, Nakamura K, Sasaki N, Murakami M, Rajapakshage W, Kumara B, Tamura Y, Lim SY, Ohta H, Takiguchi M.

J Parasitol. 2011 Dec;97(6):1190-2. doi: 10.1645/GE-2799.1. Epub 2011 Jul 14.

PMID:
21756054

Supplemental Content

Loading ...
Support Center